HEADER TRANSFERASE 29-AUG-22 8AW1 TITLE C-MET Y1235D MUTANT IN COMPLEX WITH TEPOTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 6 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR U.GRAEDLER,A.LAMMENS REVDAT 2 20-MAR-24 8AW1 1 JRNL REVDAT 1 06-SEP-23 8AW1 0 JRNL AUTH U.GRADLER,D.SCHWARZ,A.WEGENER,T.EICHHORN,T.M.BANDEIRAS, JRNL AUTH 2 M.C.FREITAS,A.LAMMENS,O.GANICHKIN,M.AUGUSTIN,S.MINGUZZI, JRNL AUTH 3 F.BECKER,J.BOMKE JRNL TITL BIOPHYSICAL AND STRUCTURAL CHARACTERIZATION OF THE IMPACTS JRNL TITL 2 OF MET PHOSPHORYLATION ON TEPOTINIB BINDING. JRNL REF J.BIOL.CHEM. V. 299 05328 2023 JRNL REFN ESSN 1083-351X JRNL PMID 37806493 JRNL DOI 10.1016/J.JBC.2023.105328 REMARK 2 REMARK 2 RESOLUTION. 2.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (8-JUN-2022) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 32217 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.850 REMARK 3 FREE R VALUE TEST SET COUNT : 1564 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 51 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.15 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.65 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 645 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3040 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 619 REMARK 3 BIN R VALUE (WORKING SET) : 0.3055 REMARK 3 BIN FREE R VALUE : 0.2709 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.03 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 26 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4232 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 237 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.85 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.98260 REMARK 3 B22 (A**2) : -1.23810 REMARK 3 B33 (A**2) : 2.22070 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.20320 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.290 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.272 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.195 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.267 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.196 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4426 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5982 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1516 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 714 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4426 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 546 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3675 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.88 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.91 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.54 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|1066 - A|1159 } REMARK 3 ORIGIN FOR THE GROUP (A): 32.3260 9.5754 9.0881 REMARK 3 T TENSOR REMARK 3 T11: -0.0321 T22: -0.0579 REMARK 3 T33: -0.0868 T12: 0.0125 REMARK 3 T13: 0.0498 T23: 0.0710 REMARK 3 L TENSOR REMARK 3 L11: 2.3570 L22: 1.5980 REMARK 3 L33: 9.3035 L12: 0.3255 REMARK 3 L13: -2.1022 L23: -0.1995 REMARK 3 S TENSOR REMARK 3 S11: -0.0126 S12: 0.4674 S13: 0.1661 REMARK 3 S21: -0.1927 S22: 0.1867 S23: -0.0137 REMARK 3 S31: -0.0656 S32: -0.6193 S33: -0.1741 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A|1160 - A|1345 } REMARK 3 ORIGIN FOR THE GROUP (A): 35.7683 -2.9469 30.9073 REMARK 3 T TENSOR REMARK 3 T11: -0.0201 T22: -0.0887 REMARK 3 T33: 0.0379 T12: 0.0362 REMARK 3 T13: 0.0248 T23: -0.0186 REMARK 3 L TENSOR REMARK 3 L11: 1.3757 L22: 0.8840 REMARK 3 L33: 1.0766 L12: 0.0028 REMARK 3 L13: 0.2142 L23: -0.6251 REMARK 3 S TENSOR REMARK 3 S11: 0.0535 S12: 0.1315 S13: -0.1265 REMARK 3 S21: -0.0649 S22: -0.0461 S23: -0.0013 REMARK 3 S31: 0.0817 S32: 0.0953 S33: -0.0074 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { B|1064 - B|1159 } REMARK 3 ORIGIN FOR THE GROUP (A): -4.8363 11.3050 9.0963 REMARK 3 T TENSOR REMARK 3 T11: 0.0672 T22: 0.0822 REMARK 3 T33: -0.1929 T12: 0.1534 REMARK 3 T13: 0.0046 T23: 0.1173 REMARK 3 L TENSOR REMARK 3 L11: 4.3055 L22: 1.7895 REMARK 3 L33: 3.2130 L12: -0.3654 REMARK 3 L13: 0.1648 L23: -1.6529 REMARK 3 S TENSOR REMARK 3 S11: 0.2650 S12: 0.9840 S13: 0.3031 REMARK 3 S21: -0.3307 S22: -0.1371 S23: 0.2042 REMARK 3 S31: -0.1003 S32: -0.1360 S33: -0.1278 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { B|1160 - B|1345 } REMARK 3 ORIGIN FOR THE GROUP (A): -2.0316 -0.8196 30.7570 REMARK 3 T TENSOR REMARK 3 T11: -0.0140 T22: -0.1022 REMARK 3 T33: 0.0119 T12: 0.0336 REMARK 3 T13: 0.0204 T23: -0.0099 REMARK 3 L TENSOR REMARK 3 L11: 1.7205 L22: 1.0149 REMARK 3 L33: 1.2784 L12: -0.3174 REMARK 3 L13: 0.2103 L23: -0.4176 REMARK 3 S TENSOR REMARK 3 S11: 0.0876 S12: 0.0067 S13: -0.1188 REMARK 3 S21: -0.1672 S22: -0.0288 S23: 0.0784 REMARK 3 S31: 0.0043 S32: -0.0226 S33: -0.0589 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8AW1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1292125130. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-FEB-14 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32217 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.140 REMARK 200 RESOLUTION RANGE LOW (A) : 89.280 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05600 REMARK 200 FOR THE DATA SET : 12.9100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.44100 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4R1V REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8,000, PH 6.5, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.64550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 ASP A 1054 REMARK 465 LEU A 1055 REMARK 465 SER A 1056 REMARK 465 ALA A 1057 REMARK 465 LEU A 1058 REMARK 465 ASN A 1059 REMARK 465 PRO A 1060 REMARK 465 GLU A 1061 REMARK 465 LEU A 1062 REMARK 465 VAL A 1063 REMARK 465 GLN A 1064 REMARK 465 ALA A 1065 REMARK 465 ARG A 1114 REMARK 465 ILE A 1115 REMARK 465 THR A 1116 REMARK 465 ASP A 1117 REMARK 465 ILE A 1118 REMARK 465 GLY A 1119 REMARK 465 SER A 1149 REMARK 465 GLU A 1150 REMARK 465 GLY A 1151 REMARK 465 SER A 1236 REMARK 465 VAL A 1237 REMARK 465 HIS A 1238 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 465 ALA A 1243 REMARK 465 GLY A 1346 REMARK 465 GLU A 1347 REMARK 465 HIS A 1348 REMARK 465 TYR A 1349 REMARK 465 VAL B 1051 REMARK 465 HIS B 1052 REMARK 465 ILE B 1053 REMARK 465 ASP B 1054 REMARK 465 LEU B 1055 REMARK 465 SER B 1056 REMARK 465 ALA B 1057 REMARK 465 LEU B 1058 REMARK 465 ASN B 1059 REMARK 465 PRO B 1060 REMARK 465 GLU B 1061 REMARK 465 LEU B 1062 REMARK 465 VAL B 1063 REMARK 465 ASN B 1100 REMARK 465 ASP B 1101 REMARK 465 GLY B 1102 REMARK 465 ILE B 1115 REMARK 465 THR B 1116 REMARK 465 ASP B 1117 REMARK 465 ILE B 1118 REMARK 465 SER B 1149 REMARK 465 GLU B 1150 REMARK 465 GLY B 1151 REMARK 465 ASP B 1235 REMARK 465 SER B 1236 REMARK 465 VAL B 1237 REMARK 465 HIS B 1238 REMARK 465 ASN B 1239 REMARK 465 LYS B 1240 REMARK 465 THR B 1241 REMARK 465 GLY B 1242 REMARK 465 GLY B 1346 REMARK 465 GLU B 1347 REMARK 465 HIS B 1348 REMARK 465 TYR B 1349 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLN A 1067 CG CD OE1 NE2 REMARK 480 HIS A 1068 CG ND1 CD2 CE1 NE2 REMARK 480 ARG A 1086 CG CD NE CZ NH1 NH2 REMARK 480 PHE A 1089 CB CG CD1 CD2 CE1 CE2 CZ REMARK 480 ASN A 1100 CB CG OD1 ND2 REMARK 480 ASP A 1101 CB CG OD1 OD2 REMARK 480 LYS A 1104 CG CD CE NZ REMARK 480 GLU A 1120 CG CD OE1 OE2 REMARK 480 GLN A 1123 CB CG CD OE1 NE2 REMARK 480 ILE A 1130 CG1 CG2 CD1 REMARK 480 LYS A 1132 CG CD CE NZ REMARK 480 ILE A 1145 CD1 REMARK 480 LEU A 1147 CB CG CD1 CD2 REMARK 480 THR A 1173 CB OG1 CG2 REMARK 480 LYS A 1215 CG CD CE NZ REMARK 480 GLU A 1233 CG CD OE1 OE2 REMARK 480 ASP A 1235 CG OD1 OD2 REMARK 480 LYS A 1244 CD CE NZ REMARK 480 ASP A 1286 CG OD1 OD2 REMARK 480 ASN A 1288 CG OD1 ND2 REMARK 480 PHE A 1290 CG CD1 CD2 CE1 CE2 CZ REMARK 480 LYS A 1323 CD CE NZ REMARK 480 GLN B 1067 CG CD OE1 NE2 REMARK 480 HIS B 1068 CG ND1 CD2 CE1 NE2 REMARK 480 ILE B 1071 CG1 CG2 CD1 REMARK 480 GLU B 1082 CG CD OE1 OE2 REMARK 480 ARG B 1086 CG CD NE CZ NH1 NH2 REMARK 480 LEU B 1097 CD1 CD2 REMARK 480 LEU B 1098 CD1 CD2 REMARK 480 LYS B 1103 CE NZ REMARK 480 LYS B 1104 CG CD CE NZ REMARK 480 ILE B 1105 CG1 CG2 CD1 REMARK 480 VAL B 1121 CB CG1 CG2 REMARK 480 SER B 1122 OG REMARK 480 PHE B 1124 CB CG CD1 CD2 CE1 CE2 CZ REMARK 480 LEU B 1125 CG CD1 CD2 REMARK 480 LEU B 1147 CG CD1 CD2 REMARK 480 LYS B 1215 CE NZ REMARK 480 TYR B 1234 CB CG CD1 CD2 CE1 CE2 CZ REMARK 480 TYR B 1234 OH REMARK 480 LYS B 1244 CD CE NZ REMARK 480 GLN B 1258 CG CD OE1 NE2 REMARK 480 LYS B 1259 CG CD CE NZ REMARK 480 LYS B 1323 CD CE NZ REMARK 480 ILE B 1345 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A1203 -13.77 80.21 REMARK 500 ASP A1204 48.96 -141.69 REMARK 500 ALA A1221 -163.84 -124.71 REMARK 500 GLU A1233 45.75 -92.86 REMARK 500 ARG B1203 -7.96 76.89 REMARK 500 ASP B1204 44.90 -148.27 REMARK 500 ALA B1221 -163.21 -123.92 REMARK 500 GLU B1233 39.67 -94.33 REMARK 500 REMARK 500 REMARK: NULL DBREF 8AW1 A 1051 1349 UNP P08581 MET_HUMAN 1051 1349 DBREF 8AW1 B 1051 1349 UNP P08581 MET_HUMAN 1051 1349 SEQADV 8AW1 ASP A 1235 UNP P08581 TYR 1235 ENGINEERED MUTATION SEQADV 8AW1 ASP B 1235 UNP P08581 TYR 1235 ENGINEERED MUTATION SEQRES 1 A 299 VAL HIS ILE ASP LEU SER ALA LEU ASN PRO GLU LEU VAL SEQRES 2 A 299 GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER LEU SEQRES 3 A 299 ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE SEQRES 4 A 299 GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP GLY SEQRES 5 A 299 LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG ILE SEQRES 6 A 299 THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU GLY SEQRES 7 A 299 ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SER SEQRES 8 A 299 LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO LEU SEQRES 9 A 299 VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG ASN SEQRES 10 A 299 PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS ASP SEQRES 11 A 299 LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET LYS SEQRES 12 A 299 TYR LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU ALA SEQRES 13 A 299 ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL LYS SEQRES 14 A 299 VAL ALA ASP PHE GLY LEU ALA ARG ASP MET TYR ASP LYS SEQRES 15 A 299 GLU TYR ASP SER VAL HIS ASN LYS THR GLY ALA LYS LEU SEQRES 16 A 299 PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR GLN SEQRES 17 A 299 LYS PHE THR THR LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 18 A 299 LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO TYR SEQRES 19 A 299 PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU LEU SEQRES 20 A 299 GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP SEQRES 21 A 299 PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO LYS SEQRES 22 A 299 ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SER ARG SEQRES 23 A 299 ILE SER ALA ILE PHE SER THR PHE ILE GLY GLU HIS TYR SEQRES 1 B 299 VAL HIS ILE ASP LEU SER ALA LEU ASN PRO GLU LEU VAL SEQRES 2 B 299 GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER LEU SEQRES 3 B 299 ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE SEQRES 4 B 299 GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP GLY SEQRES 5 B 299 LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG ILE SEQRES 6 B 299 THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU GLY SEQRES 7 B 299 ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SER SEQRES 8 B 299 LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO LEU SEQRES 9 B 299 VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG ASN SEQRES 10 B 299 PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS ASP SEQRES 11 B 299 LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET LYS SEQRES 12 B 299 TYR LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU ALA SEQRES 13 B 299 ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL LYS SEQRES 14 B 299 VAL ALA ASP PHE GLY LEU ALA ARG ASP MET TYR ASP LYS SEQRES 15 B 299 GLU TYR ASP SER VAL HIS ASN LYS THR GLY ALA LYS LEU SEQRES 16 B 299 PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR GLN SEQRES 17 B 299 LYS PHE THR THR LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 18 B 299 LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO TYR SEQRES 19 B 299 PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU LEU SEQRES 20 B 299 GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP SEQRES 21 B 299 PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO LYS SEQRES 22 B 299 ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SER ARG SEQRES 23 B 299 ILE SER ALA ILE PHE SER THR PHE ILE GLY GLU HIS TYR HET 3E8 A1401 37 HET 3E8 B1401 37 HETNAM 3E8 3-[1-(3-{5-[(1-METHYLPIPERIDIN-4-YL)METHOXY]PYRIMIDIN- HETNAM 2 3E8 2-YL}BENZYL)-6-OXO-1,6-DIHYDROPYRIDAZIN-3- HETNAM 3 3E8 YL]BENZONITRILE FORMUL 3 3E8 2(C29 H28 N6 O2) FORMUL 5 HOH *237(H2 O) HELIX 1 AA1 VAL A 1066 HIS A 1068 5 3 HELIX 2 AA2 GLY A 1072 SER A 1074 5 3 HELIX 3 AA3 VAL A 1121 ILE A 1129 1 9 HELIX 4 AA4 ILE A 1130 PHE A 1134 5 5 HELIX 5 AA5 ASP A 1164 ASN A 1171 1 8 HELIX 6 AA6 THR A 1177 LYS A 1198 1 22 HELIX 7 AA7 ALA A 1206 ARG A 1208 5 3 HELIX 8 AA8 PHE A 1223 ARG A 1227 5 5 HELIX 9 AA9 PRO A 1246 MET A 1250 5 5 HELIX 10 AB1 ALA A 1251 GLN A 1258 1 8 HELIX 11 AB2 THR A 1261 THR A 1278 1 18 HELIX 12 AB3 ASN A 1288 PHE A 1290 5 3 HELIX 13 AB4 ASP A 1291 GLN A 1298 1 8 HELIX 14 AB5 PRO A 1309 TRP A 1320 1 12 HELIX 15 AB6 LYS A 1323 ARG A 1327 5 5 HELIX 16 AB7 SER A 1329 THR A 1343 1 15 HELIX 17 AB8 ALA B 1065 HIS B 1068 5 4 HELIX 18 AB9 GLY B 1072 SER B 1074 5 3 HELIX 19 AC1 GLU B 1120 ILE B 1129 1 10 HELIX 20 AC2 ILE B 1130 PHE B 1134 5 5 HELIX 21 AC3 ASP B 1164 ASN B 1171 1 8 HELIX 22 AC4 THR B 1177 LYS B 1198 1 22 HELIX 23 AC5 ALA B 1206 ARG B 1208 5 3 HELIX 24 AC6 PHE B 1223 ARG B 1227 5 5 HELIX 25 AC7 PRO B 1246 MET B 1250 5 5 HELIX 26 AC8 ALA B 1251 GLN B 1258 1 8 HELIX 27 AC9 THR B 1261 THR B 1278 1 18 HELIX 28 AD1 ASN B 1288 PHE B 1290 5 3 HELIX 29 AD2 ASP B 1291 GLN B 1298 1 8 HELIX 30 AD3 PRO B 1309 TRP B 1320 1 12 HELIX 31 AD4 LYS B 1323 ARG B 1327 5 5 HELIX 32 AD5 SER B 1329 THR B 1343 1 15 SHEET 1 AA1 6 VAL A1070 ILE A1071 0 SHEET 2 AA1 6 GLY A1144 CYS A1146 1 O ILE A1145 N ILE A1071 SHEET 3 AA1 6 LEU A1154 PRO A1158 -1 O VAL A1156 N GLY A1144 SHEET 4 AA1 6 LYS A1104 SER A1111 -1 N LYS A1110 O VAL A1155 SHEET 5 AA1 6 CYS A1091 LEU A1098 -1 N TYR A1093 O VAL A1109 SHEET 6 AA1 6 LEU A1076 ARG A1086 -1 N GLY A1085 O VAL A1092 SHEET 1 AA2 2 CYS A1210 LEU A1212 0 SHEET 2 AA2 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 AA3 6 VAL B1070 ILE B1071 0 SHEET 2 AA3 6 GLY B1144 CYS B1146 1 O ILE B1145 N ILE B1071 SHEET 3 AA3 6 LEU B1154 PRO B1158 -1 O VAL B1156 N GLY B1144 SHEET 4 AA3 6 ILE B1105 SER B1111 -1 N LYS B1110 O VAL B1155 SHEET 5 AA3 6 CYS B1091 LEU B1097 -1 N TYR B1093 O VAL B1109 SHEET 6 AA3 6 LEU B1076 ARG B1086 -1 N GLY B1085 O VAL B1092 SHEET 1 AA4 2 CYS B1210 LEU B1212 0 SHEET 2 AA4 2 VAL B1218 VAL B1220 -1 O LYS B1219 N MET B1211 CRYST1 77.833 43.291 89.286 90.00 90.60 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012848 0.000000 0.000135 0.00000 SCALE2 0.000000 0.023099 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011201 0.00000